Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004727 · ClinicalTrials.gov registry record · Phase 4
Antiplatelet Therapy to Prevent Stroke in African Americans
A Phase 4 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 4
- Development phase
NCT00004727 is a Phase 4 study that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS).
The verdict
NCT00004727, a Phase 4 study, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The African-American Antiplatelet Stroke Prevention Study is designed to prevent recurrent strokes by administration of aspirin or ticlopidine. The study also provides community information on reducing risk of stroke and recognizing the symptoms of stroke. The study involves more than 50 participating hospitals located throughout the United States. Study medication is provided free of charge, and a transportation stipend is available for those in need.
Interventions
- DRUG aspirin
- DRUG ticlopidine
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004727
The ClinicalTrials.gov registry entry for NCT00004727 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which aspirin is the first listed.
NCT00004727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004727 about?
NCT00004727 is a clinical study titled "Antiplatelet Therapy to Prevent Stroke in African Americans". The African-American Antiplatelet Stroke Prevention Study is designed to prevent recurrent strokes by administration of aspirin or ticlopidine. The study also provides community information on reducing risk of stroke and recognizing the symptoms of stroke. The study involves more than 50 participati...
What is the current status of trial NCT00004727?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00004727?
The interventions under investigation include: aspirin (DRUG), ticlopidine (DRUG).
Who is sponsoring clinical trial NCT00004727?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.